Search Advanced Search
Sign-up for Free Trial
Law360 - The Newswire for Business Lawyers
Subscribe | Sign In
Platform Tools
  • Cases
  • Tracking
  • News Sections
  • Jobs

Overall

All cases

Advanced search

Key cases

Class actions

Public companies

Industries

Banking & finance

Consumer goods

Health

Hospitality

Life sciences

Media & entertainment

Oil & gas

Retail

Technology

Intellectual Property

Copyright

Patent

Trademark

Labor & Employment

Employment class actions

Discrimination

ERISA

Labor/management

Corporate

Antitrust

Bankruptcy appeals

Commercial contracts

Environmental

Insurance

Product liability

Real estate

Securities

Tax

Practice Areas

Appellate

Bankruptcy

Class Action

Commercial Contracts

Competition

Corporate

Employment

Environmental

Government Contracts

Insurance

Intellectual Property

International Trade

Mergers & Acquisitions

Privacy

Product Liability

Project Finance

Public Policy

Securities

White Collar

Industries

Banking

Energy

Health

Life Sciences

Media & Entertainment

Private Equity

Real Estate

Technology

Regions

California

Florida

New Jersey

New York

Pennsylvania

Texas

Legal Industry

Law Firms

Companies

Industries

Government Agencies

E-mail Report on Mylan Inc
Healthcare » Drugs - Generic » Mylan Inc

Mylan Inc

Alert me of new articles

  • Everything »
  • News & Analysis »
  • Cases »
  • Outside Counsel »

Sections

  • Appellate (106)
  • Banking (7)
  • California (29)
  • Class Action (44)
  • Commercial Contracts (13)
  • Competition (157)
  • Corporate (28)
  • Employment (3)
  • Energy (4)
  • Florida (38)
  • Government Contracts (35)
  • Health (594)
  • Insurance (8)
  • Intellectual Property (633)
  • International Trade (4)
  • Legal Industry (2)
  • Life Sciences (770)
  • Media & Entertainment (1)
  • Mergers & Acquisitions (23)
  • Midwest (83)
  • New Jersey (189)
  • New York (107)
  • Pennsylvania (78)
  • Privacy (3)
  • Private Equity (1)
  • Product Liability (41)
  • Public Policy (29)
  • Securities (10)
  • Southeast (117)
  • Technology (4)
  • Texas (26)
  • Top News (28)
  • White Collar (4)
Name Count
Search News Advanced Search

RSSNews (781)

  1. March 25, 2013 Watson Can't Skirt Shire's Colitis Drug Patent Suit

    ... generic drugmaker, Mylan Pharmaceuticals Inc., from making a generic version of Lialda before...

  2. March 25, 2013 Actavis, AstraZeneca Settle Crestor Generic Suit

    ... drugmakers — including Mylan Pharmaceuticals Inc. and Sandoz Inc. — challenged the validity of...

  3. March 21, 2013 AstraZeneca Pushes DC Circ. To Stretch Seroquel Exclusivity
  4. March 15, 2013 UK Court Revokes 2 Novartis Patents In Bone Drug Row

    ... makers Hospira UK Ltd. and Mylan Inc. that Novartis AG wasn't the first to discover its effectiveness...

  5. March 13, 2013 Mylan Settles Fortamet Patent Suit With Shionogi, Andrx

    ...Mylan Pharmaceuticals Inc. has settled a patent infringement suit brought by Shionogi Inc. and...

  6. March 11, 2013 Mylan Says Teva's MS Drug IP Suit Doomed By Safe Harbor

    ...Mylan Inc. on Friday asked a New York federal judge to toss a patent infringement suit over Teva...

  7. March 11, 2013 Merck, BMS Target Hetero Over Generic HIV Drug Sustiva

    ..., it sued Matrix Laboratories Ltd. and Mylan Pharmaceuticals Inc., which were planning to make a...

  8. March 8, 2013 Warner 'Confused' About Doryx Contracts, Retailers Say

    ... the drug. The retail outlets, now joined in the consolidated case by Mylan...

  9. March 5, 2013 Pfizer Targets Generic Celebrex After Extending Patent

    ... Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Watson Laboratories Inc., Lupin Pharmaceuticals USA Inc...

  10. March 1, 2013 Supreme Court Warned Of Risks Of Banning Pay-For-Delay

    ... Pharmaceuticals USA Inc., Ranbaxy Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. and Impax Laboratories Inc...

  11. February 28, 2013 Warner Chilcott Says Contracts Bar Retailers' Doryx Suit

    ... /> A consolidated case in Pennsylvania federal court, which includes Mylan Pharmaceuticals Inc...

  12. February 28, 2013 Skadden Reps Mylan In $1.6B Buy Of Indian Generics Maker

    ...Mylan Inc. has agreed to purchase a generic-drug maker from Indian pharmaceutical giant Strides...

  13. February 26, 2013 Judge Axes $500M FCA Suit Over Public Info-Based Claims

    ... defendants in the suit are Mylan Inc., Biovail Corp., Teva Pharmaceuticals USA Inc. and Healthpoint Ltd.

  14. February 21, 2013 Teva Slams Antitrust Claims In Azilect Patent Row

    ... generic drugmakers Watson Laboratories Inc., Mylan Pharmaceuticals Inc., Orchid Chemicals &...

  15. February 15, 2013 Q&A With O'Melveny's Bob Siegel

    ... Corporation and Mylan Laboratories. Q: What is the most challenging case you have worked...

  16. February 14, 2013 Fed. Circ. Backs AstraZeneca Win In Seroquel XR Patent Row

    ... their decision for doing so. In the March ruling, Judge Pisano found that generics makers Mylan Inc...

  17. February 14, 2013 Impax's Appeal Too Late In Amrix Case, Fed. Circ. Says

    ... /> In a patent suit Teva Pharmaceutical Industries Ltd.'s Cephalon had brought against Impax, Mylan...

  18. February 14, 2013 Generic Fentora Doesn't Violate Teva IP, Fed. Circ. Finds

    ... the two patents that were revived on Thursday, and four others in a separate case against Mylan Inc...

  19. February 13, 2013 Upsher, Forest Ink $11M Drug Price Inflation Settlement

    .... in September 2011, and $65 million from Mylan Pharmaceuticals Inc. in January 2011.

  20. February 11, 2013 GSK Lobs False Ad Suit At Teva Over Axed Wellbutrin Generic

    ... Pharmaceuticals Inc., Actavis Inc. and Mylan Inc. — are being asked to report back by March on the...

Show:
← Previous 1 2 3 4 5 6 7 8 9 … 39 40 Next →
Export to Excel

© Copyright 2013, Portfolio Media, Inc. | Home | About | Contact Us | Site Map | Site Index | Jobs | Careers at Law360 | Mobile | Terms

Track docs | Track attorneys | Track judges